MDT

83.06

+0.24%↑

VEEV

213.48

-0.09%↓

A

103.34

+2.82%↑

HQY

80.25

+4.9%↑

PDCO

30.85

-0.29%↓

MDT

83.06

+0.24%↑

VEEV

213.48

-0.09%↓

A

103.34

+2.82%↑

HQY

80.25

+4.9%↑

PDCO

30.85

-0.29%↓

MDT

83.06

+0.24%↑

VEEV

213.48

-0.09%↓

A

103.34

+2.82%↑

HQY

80.25

+4.9%↑

PDCO

30.85

-0.29%↓

MDT

83.06

+0.24%↑

VEEV

213.48

-0.09%↓

A

103.34

+2.82%↑

HQY

80.25

+4.9%↑

PDCO

30.85

-0.29%↓

MDT

83.06

+0.24%↑

VEEV

213.48

-0.09%↓

A

103.34

+2.82%↑

HQY

80.25

+4.9%↑

PDCO

30.85

-0.29%↓

Search

Bausch Health Cos Inc

Open

SectorGezondheidszorg

5.3 -0.38

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

4.74

Max

5.32

Belangrijke statistieken

By Trading Economics

Inkomsten

190M

98M

Verkoop

49M

2.6B

EPS

1.16

Winstmarge

3.83

Werknemers

20,700

EBITDA

206M

853M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+62.66% upside

Dividenden

By Dow Jones

Volgende Winsten

30 apr 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

50M

2.4B

Vorige openingsprijs

5.68

Vorige sluitingsprijs

5.3

Nieuwssentiment

By Acuity

55%

45%

299 / 386 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bearish Evidence

Bausch Health Cos Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

17 okt 2024, 23:57 UTC

Populaire aandelen

Stocks to Watch: Netflix, MGP Ingredients, Bausch Health

Peer Vergelijking

Prijswijziging

Bausch Health Cos Inc Prognose

Koersdoel

By TipRanks

62.66% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 8.67 USD  62.66%

Hoogste 12 USD

Laagste 7 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Bausch Health Cos Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

6 ratings

0

Buy

5

Hold

1

Sell

Technische score

By Trading Central

N/A / 6.25Steun & Weerstand

Korte Termijn

Strong Bearish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

299 / 386 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Bausch Health Cos Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.